The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used as a standalone treatment for patients with severe depression ...

Imagine a world where woolly mammoths roam the tundra once more—not in a prehistoric dream but as a living, breathing reality. This isn’t science fiction; it’s cutting-edge science happening ...

A startup company is trying to raise money to bring back the woolly mammoth. Colossal Biosciences Inc. uses DNA and genomics in hopes of re-introducing extinct animals to the modern-day world.

Instead of dinosaurs, Colossal has set its sights on more recently lost species including the dodo, the thylacine — also known as the Tasmanian tiger– and the woolly mammoth. The last ...

She came out like a wooly mammoth and Dolly’s the best mum; a real pro. A better mummy you wouldn’t find.” To stay up to date with all the breaking news from major shows throughout 2025 ...

Treatment for sleep apnea aims to improve your breathing during sleep and reduce the risk of underlying health concerns. Common options include CPAP machines, oral devices, and lifestyle measures ...

Woolly mammoths went extinct around 4,000 years ago, but scientists claim America will soon see the prehistoric animal in 2028. Colossal Biosciences, a Texas-based biotechnology and genetic ...

Colossal Biosciences, the company that’s famously on a mission to bring back the woolly mammoth and two ... which could have applications in fertility treatment. The company has already spun ...

Digital rendering of the long-extinct woolly mammoth. Courtesy Colossal Biosciences The woolly mammoth could be brought back from extinction in just three years’ time—that is, if everything ...

(Bloomberg) -- A biotechnology startup working to bring back animals from extinction has raised $200 million at a valuation of $10.2 billion, more than six times its valuation just two years ago.

Learn More Colossal BioSciences has raised $200 million in a new round of funding to bring back extinct species like the woolly mammoth. Dallas- and Boston-based Colossal is making strides in the ...

Colossal Biosciences is using DNA and genomics to try to resurrect the dodo, Tasmanian tiger and the woolly mammoth. Co-founder and CEO Ben Lamm says the company is on track to produce a woolly ...